Uniqure

Uniqure Equity

The The Equity of Uniqure (QURE) as of Nov 16, 2026 is 198.90 M USD. In the previous year, The Equity was -6.75 M USD — a change of -3,045.81% (higher).

Equity

198.90 MUSD

YoY

-3,045.81%

Last updated:

In 2025, Uniqure's equity was 198.90 M USD, a -3,045.81% increase from the -6.75 M USD equity in the previous year.

The Uniqure Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
179.61 M USD
Jan 1, 2019
323.06 M USD
Jan 1, 2020
243.91 M USD
Jan 1, 2021
595.78 M USD
Jan 1, 2022
476.01 M USD
Jan 1, 2023
207.67 M USD
Jan 1, 2024
-6.75 M USD
Jan 1, 2025
198.90 M USD
The Uniqure Equity history
YEAREquityYoY
198.90 MUSD-3,045.81%
-6.75 MUSD-103.25%
207.67 MUSD-56.37%
476.01 MUSD-20.10%
595.78 MUSD+144.27%
243.91 MUSD-24.50%
323.06 MUSD+79.87%
179.61 MUSD+99.68%
89.95 MUSD+41.35%
63.63 MUSD-51.29%
130.63 MUSD+149.34%
52.39 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Uniqure Stock analysis

What does Uniqure do? Uniqure NV is a Dutch biotechnology company specializing in the development of gene therapies for rare diseases. The company was founded in 1999 and is headquartered in Amsterdam. Uniqure is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Uniqure's Equity

Uniqure's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Uniqure's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Uniqure's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Uniqure's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Uniqure’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Uniqure stock

The Equity of Uniqure is 198.90 M USD in 2025.

The Equity of Uniqure changed from -6.75 M USD to 198.90 M USD, representing a -3,045.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Uniqure since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Uniqure historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Uniqure

All Key Metrics — Uniqure